ESR’s strategy, key initiatives and performance measures for 2021/22 have been unveiled in our Statement of Corporate Intent (SCI).
The comprehensive plan highlights five areas of strategic focus which are:
– Understanding our value
– Shaping the future of our science
– Increasing our impact
– Building our team
– Building stronger foundations
ESR CEO Peter Lennox says that ESR is not only delivering public health solutions for today, it is actively preparing for the challenges of the future.
“We are doing this in the same way that our research and science transformation over the past five years prepared us for COVID-19.
“Responding to the health impacts of climate change and ensuring community wellbeing is enhanced are core to ESR’s work and we are pursuing science-based solutions in areas such as genomics, social systems and digital forensics.
“We are working with customers and stakeholders to continue to develop and co-create leading edge solutions.”
The SCI is required by law to be produced by a range of public entities each year. The statements are required to set out planned objectives and activities for the next three years. ESR’s SCI includes forecasts through to 2026.
Read the 2021-2026 Statement of Corporate Intent.